Cervical Cancer

China Makes GSK Cervical Cancer Vaccine Available to More Women

China Makes GSK Cervical Cancer Vaccine Available to More Women

China has extended the age range of patients eligible to receive GlaxoSmithKline’s Cervarix vaccine for human papillomavirus to between nine…

May 30, 2018
Dou Shicong
China Approves First Sales of New Cervical Cancer Vaccine

China Approves First Sales of New Cervical Cancer Vaccine

China's mainland is expected to gain access to a nine-valent vaccine for human papillomavirus for the first time after the country's drug…

May 24, 2018
Liao Shumin
China Steps Up Early Diagnosis of Cervical Cancer With Help of Robotics, Artificial Intelligence

China Steps Up Early Diagnosis of Cervical Cancer With Help of Robotics, Artificial Intelligence

China Steps Up Early Diagnosis of Cervical Cancer With Help of Robotics, Artificial Intelligence. The AI cervical cancer diagnostic robot…

Apr 16, 2018
Dou Shicong
China Trials Seven-Second Breath Test to Screen Against Cervical Cancer

China Trials Seven-Second Breath Test to Screen Against Cervical Cancer

The Medical Physics Center under the Chinese Academy of Sciences’ Hefei Institute of Physical Science has made a breakthrough in…

Oct 24, 2017
Zhang Xia
GSK to Offer First Cervical Cancer Vaccine Approved in China at Community Hospitals

GSK to Offer First Cervical Cancer Vaccine Approved in China at Community Hospitals

Britain's biggest pharmaceutical company GlaxoSmithKline Plc [NYSE:GSK] will soon begin offering China’s first approved vaccine for the prevention of cervical cancer, Cervarix, in community hospitals…

Aug 1, 2017
Dou Shicong